Cargando…
Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders
The efficacy mepolizumab in severe asthmatic patients is proven in the literature. Primarily to study the effect of mepolizumab on exacerbations, steroid dependence, and the continuation of efficacy in the long term. Secondarily to evaluate the effect of the drug on nasal polyps. Analyzing data from...
Autores principales: | Bagnasco, Diego, Nicola, Stefania, Testino, Elisa, Brussino, Luisa, Pini, Laura, Caminati, Marco, Piccardo, Federica, Canevari, Rikki Frank, Melissari, Laura, Ioppi, Alessandro, Guastini, Luca, Lombardi, Carlo, Milanese, Manlio, Losa, Francesca, Robbiano, Michela, De Ferrari, Laura, Riccio, Anna Maria, Guida, Giuseppe, Bonavia, Marco, Fini, Donatella, Balbi, Francesco, Caruso, Cristiano, Paggiaro, Pierluigi, Blasi, Francesco, Heffler, Enrico, Paoletti, Giovanni, Canonica, Giorgio Walter, Senna, Gianenrico, Passalacqua, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525371/ https://www.ncbi.nlm.nih.gov/pubmed/37760865 http://dx.doi.org/10.3390/biomedicines11092424 |
Ejemplares similares
-
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life()
por: Bagnasco, Diego, et al.
Publicado: (2021) -
Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry
por: Puggioni, Francesca, et al.
Publicado: (2020) -
Specific Therapy for T2 Asthma
por: Bagnasco, Diego, et al.
Publicado: (2022) -
Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI
por: Senna, Gianenrico, et al.
Publicado: (2020) -
Severe asthma: One disease and multiple definitions
por: Bagnasco, Diego, et al.
Publicado: (2021)